Please use this identifier to cite or link to this item:
|Title:||Multimorbidity worsened anxiety and depression symptoms during the COVID-19 pandemic in Brazil.||Austin Authors:||Castro-de-Araujo, Luis Fernando Silva;Rodrigues, Elisângela da Silva;Machado, Daiane Borges;Henriques, Claudio Maierovitch Pessanha;Verotti, Mariana Pastorello;Gonçalves, Alessandra Queiroga;Duarte-Salles, Talita;Kanaan, Richard A A ;Barreto, Mauricio Lima;Lewis, Glyn;Barbosa, Jakeline Ribeiro||Affiliation:||Psychiatry (University of Melbourne)
Center of Data and Knowledge Integration for Health (CIDACS), Fiocruz, Salvador, Brazil..
Federal University of Ceará, Campus Jardins de Anita, Itapajé, Ceará, Brazil..
Harvard Medical School, Department Global Health and Social Medicine, United States of America..
Center for Epidemiology and Health Surveillance, Oswaldo Cruz Foundation, Brasília, Brazil..
Unitat de Suport a la Recerca Terres de l'Ebre, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Tortosa, Catalunya, Spain..
Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain..
Division of Psychiatry, UCL, London, United Kingdom of Great Britain and Northern Ireland..
Unitat Docent de Medicina de Família i Comunitària Tortosa-Terres de L'Ebre, Institut Català de la Salut, Tortosa, Catalunya, Spain..
|Issue Date:||1-Oct-2022||metadata.dc.date:||2022||Publication information:||Journal of Affective Disorders 2022; 314: 86-93||Abstract:||Multimorbidity is a global health issue impacting the quality of life of all ages. Multimorbidity with a mental disorder is little studied and is likely to have been affected by the COVID-19 pandemic. We used a survey of 14,007 respondents living in Brazil to investigate whether people who already had at least one chronic medical condition had more depression and anxiety symptoms during social distancing in 2020. Generalized linear models and structural equation modelling were used to estimate the effects. A 19 % and 15 % increase in depressive symptoms were found in females and males, respectively, for each unit of increase in the observed value of reported chronic disease. Older subjects presented fewer symptoms of depression and anxiety. There was a 16 % increase in anxiety symptoms in females for each unit increase in the reported chronic disease variable and a 14 % increase in males. Younger subjects were more affected by anxiety symptoms in a dose-response fashion. High income was significantly related to fewer depressive and anxiety symptoms in both males and females. Physical activity was significantly associated with fewer anxiety and depression symptoms. Structural equation modelling confirmed these results and provided further insight into the hypothesised paths.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/30727||DOI:||10.1016/j.jad.2022.07.005||ORCID:||0000-0003-0992-1917||PubMed URL:||35810830||PubMed URL:||https://pubmed.ncbi.nlm.nih.gov/35810830/||Type:||Journal Article||Subjects:||Anxiety
|Appears in Collections:||Journal articles|
Show full item record
checked on Oct 1, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.